Trombly Amy Moss 4
4 · Sonoma Pharmaceuticals, Inc. · Filed Jan 14, 2022
Insider Transaction Report
Form 4
Trombly Amy Moss
Chief Executive Officer
Transactions
- Award
Stock option (right to buy)
2022-01-14+30,000→ 73,648 totalExercise: $4.60Exp: 2032-01-14→ Common stock (30,000 underlying)
Footnotes (2)
- [F1]The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control.
- [F2]The options were awarded and granted to Ms. Trombly for services performed.